October 17, 2017 2:04 AM ET

Biotechnology

Company Overview of Biocartis NV

Key Executives for Biocartis NV

NameBoard RelationshipsTitleAge
Hilde Windels Msc35 RelationshipsInterim CEO & Director51
Nader Donzel No RelationshipsCo-Founder--
Ewoud Welten Msc.No RelationshipsChief Financial Officer33
Ulrik Cordes MScNo RelationshipsExecutive Vice President of Pharma Collaborations & Companion Diagnostics46
Hilde Eylenbosch M.D.16 RelationshipsChief Commercial Officer & Director53
View More Key Executives

Biocartis NV Board Members*

NameBoard RelationshipsPrimary CompanyAge
Rudi M. Marien 69 RelationshipsBiovest72
Hilde Windels Msc 35 RelationshipsBiocartis NV51
Hilde Eylenbosch M.D. 16 RelationshipsBiocartis Group NV53
Geert Maertens Ph.D. 15 RelationshipsGENimmune NV--
Rudi Pauwels Ph.D. 57 RelationshipsBiocartis Group NV57
View All Board Members

Biocartis NV Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board Ph.D.Geert Maertens15 Relationships8 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
390.0K
Bonus
242.8K
Total Short Term Compensation
486.0K
Total Value of Options
18.0M
Compensation as of Fiscal Year
Biocartis NV CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Silence Therapeutics plc Appoints Annalisa Jenkins as Non-Executive Chair of Board of Directors
October 16, 2017 6:00 AM ET
Ablynx, Inc. Appoints Daniel Schneider as General Manager
October 16, 2017 5:01 AM ET
Cellmid Limited Appoints Martin Cross as Non-Executive Director
October 15, 2017 9:47 PM ET
Navidea Biopharmaceuticals, Inc Announces Board Changes
October 13, 2017 8:01 PM ET
BioAegis Therapeutics, Inc. Hires Mark J. Dinubile as Chief Medical Officer
October 13, 2017 2:00 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Biocartis NV, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.